DexCom Inc (DXCM)-医療機器分野:企業M&A・提携分析

◆英語タイトル:DexCom Inc (DXCM) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011099
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月21日
◆ページ数:55
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
DexCom Inc (DexCom) is a medical device company that performs design, development and commercialization of continuous glucose monitoring systems for ambulatory and in-hospital use. The company’s major products include DexCom G4, DexCom G4 Platinum and other continuous glucose monitoring systems. DexCom’s in-hospital product, GlucoClear, is a blood-based in-vivo automated glucose monitoring system. It also provides training and support services. DexCom offer its products to endocrinologists, physicians, diabetes educators and others. The company distributes its products in the US, Canada, Australia, New Zealand, Europe, Asia, Latin America and the Middle East through direct sales force and a network of distributors. DexCom is headquartered in San Diego, California, the US.

DexCom Inc (DXCM) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
DexCom Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
DexCom Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
DexCom Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
DexCom Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
DexCom Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
DexCom Inc, Medical Equipment, Deal Details 11
Venture Financing 11
DexCom Raises USD7.2 Million in Venture Financing 11
Partnerships 12
Dexcom Amends Licensing Agreement with Google Life Sciences 12
Tandem Expands Licensing Agreement With Dexcom For Glucose Monitoring System 13
Tandem Diabetes Enters Into Licensing Agreement With DexCom 14
DexCom Enters into Agreement with Eli Lilly 15
Ascensia Diabetes Care Enters into Agreement with DexCom 16
Apple Enters into Agreement with DexCom 17
Tandem Diabetes Care Enters into Co-Development Agreement with Dexcom 18
Glooko Enters into Agreement with Dexcom 19
Julphar Enters Into Co-Marketing Agreement With Dexcom 20
Roche Diagnostics Enters Into Distribution Agreement With DexCom 21
Roche Diagnostics Enters Into Research And Development Agreement With DexCom 22
Equity Offering 23
DexCom Completes Public Offering Of Common Stock For US$71.4 Million 23
Debt Offering 24
DexCom Raises USD350 Million in Private Placement of 0.75% Notes Due 2022 24
Acquisition 25
DexCom to Acquire Nintamed 25
DexCom Completes Acquisition Of SweetSpot Diabetes Care For Up To US$8.5 Million 26
DexCom Inc – Key Competitors 27
DexCom Inc – Key Employees 28
DexCom Inc – Locations And Subsidiaries 29
Head Office 29
Other Locations & Subsidiaries 29
Recent Developments 30
Strategy And Business Planning 30
Nov 14, 2016: Diabetes Management Leader Dexcom Expands Presence in EMEA Markets with new Edinburgh HQ 30
Jun 20, 2016: Dexcom to Expand Manufacturing Operations to Greater Phoenix, Arizona 31
Financial Announcements 32
Nov 01, 2017: DexCom Reports Record Third Quarter 2017 Financial Results 32
Aug 01, 2017: DexCom Reports Second Quarter 2017 Financial Results 33
May 02, 2017: DexCom Reports First Quarter 2017 Financial Results 34
Feb 28, 2017: DexCom Reports Fourth Quarter and Fiscal Year 2016 Financial Results 35
Jan 10, 2017: DexCom Reports Record Preliminary, Unaudited Revenue for the Fourth Quarter and Fiscal Year 2016 and Provides Initial 2017 Outlook 36
Nov 01, 2016: DexCom Reports Third Quarter 2016 Financial Results 37
Aug 02, 2016: DexCom Reports Second Quarter 2016 Financial Results 38
Apr 27, 2016: DexCom Reports First Quarter 2016 Financial Results 39
Feb 23, 2016: DexCom Reports Fourth Quarter and Full Year 2015 Financial Results 40
Corporate Communications 41
Mar 13, 2017: DexCom Appoints Richard Collins to Board of Directors 41
Oct 20, 2016: Actor Derek Theler and Dexcom Take Center Stage to Raise Awareness of Diabetes 42
Product News 43
Aug 21, 2017: New Study Shows People with Type 2 Diabetes Benefit from Continuous Glucose Monitoring 43
Jun 09, 2017: New Study Shows Adults with Type 1 and Type 2 Diabetes on Multiple Daily Injections Benefit from CGM 44
Sep 07, 2016: Reimbursement of Dexcom CGM Technology for Patients with Type 1 and Type 2 Insulin-Dependent Diabetes is Now Available in Germany 46
Jun 13, 2016: Data Supports Continuous Glucose Monitoring to Reduce Need for Self-Monitoring of Blood Glucose for Type 1 Diabetes 47
Apr 11, 2016: Dexcom Issues Press Release To Supplement Previous Customer Notification 48
03/14/2016: Dexcom G5 Mobile Continuous Glucose Monitoring System Now Available on the Apple Watch 49
Mar 09, 2016: Dexcom continuous glucose monitor receivers 50
Other Significant Developments 51
Sep 19, 2017: DexCom Opens Data Platform and Launches Developer Program to Fuel Diabetes App Innovation 51
Sep 07, 2017: Fitbit and Dexcom to Develop Continuous Glucose Monitoring Experience for People Living with Diabetes 52
Jun 01, 2017: Glooko and Dexcom Expand Relationship With Global Cloud Sharing Data Agreement 53
May 08, 2017: Dexcom Continuous Glucose Monitoring now available on the Government Subsidy Initiative 54
Appendix 55
Methodology 55
About GlobalData 55
Contact Us 55
Disclaimer 55

List of Tables
DexCom Inc, Medical Equipment, Key Facts, 2016 2
DexCom Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
DexCom Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
DexCom Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
DexCom Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
DexCom Inc, Deals By Market, 2011 to YTD 2017 9
DexCom Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
DexCom Raises USD7.2 Million in Venture Financing 11
Dexcom Amends Licensing Agreement with Google Life Sciences 12
Tandem Expands Licensing Agreement With Dexcom For Glucose Monitoring System 13
Tandem Diabetes Enters Into Licensing Agreement With DexCom 14
DexCom Enters into Agreement with Eli Lilly 15
Ascensia Diabetes Care Enters into Agreement with DexCom 16
Apple Enters into Agreement with DexCom 17
Tandem Diabetes Care Enters into Co-Development Agreement with Dexcom 18
Glooko Enters into Agreement with Dexcom 19
Julphar Enters Into Co-Marketing Agreement With Dexcom 20
Roche Diagnostics Enters Into Distribution Agreement With DexCom 21
Roche Diagnostics Enters Into Research And Development Agreement With DexCom 22
DexCom Completes Public Offering Of Common Stock For US$71.4 Million 23
DexCom Raises USD350 Million in Private Placement of 0.75% Notes Due 2022 24
DexCom to Acquire Nintamed 25
DexCom Completes Acquisition Of SweetSpot Diabetes Care For Up To US$8.5 Million 26
DexCom Inc, Key Competitors 27
DexCom Inc, Key Employees 28
DexCom Inc, Subsidiaries 29

★海外企業調査レポート[DexCom Inc (DXCM)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • CACI International Inc. (CACI):企業の戦略的SWOT分析
    CACI International Inc. (CACI) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Ambry Genetics Corp-製薬・医療分野:企業M&A・提携分析
    Summary Ambry Genetics Corp (Ambry Genetics) is a biotechnology company that offers genetic testing services. The company offers clinical diagnostics services, which include tests, forms, billing, managed care, order kits, reporting, licenses, family studies program, variant classification and secur …
  • Swisscom Ltd (SCMN):企業の財務・戦略的SWOT分析
    Swisscom Ltd (SCMN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Progenics Pharmaceuticals, Inc.:企業の戦略・SWOT・財務分析
    Progenics Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report Summary Progenics Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Phase Holographic Imaging AB:医療機器:M&Aディール及び事業提携情報
    Summary Phase Holographic Imaging AB (PHI) is a medical device company that develops time-lapse cytometry instrumentation and software. The company’s products include HoloMonitor M4 and demo software. Its HoloMonitor time-lapse cytometers provides cellular behavior to be continuously quantified and …
  • Maximus Inc.:企業の戦略・SWOT・財務情報
    Maximus Inc. - Strategy, SWOT and Corporate Finance Report Summary Maximus Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Erytech Pharma SA (ERYP):企業の財務・戦略的SWOT分析
    Summary Erytech Pharma SA (Erytech) is a clinical-stage biopharmaceutical company that provides development of therapies for rare forms of cancer and orphan diseases. The company develops pipeline of product candidates through its proprietary ERYCAPS platform. It offers product candidates which are …
  • AutoGenomics Inc-医療機器分野:企業M&A・提携分析
    Summary AutoGenomics Inc (AutoGenomics) is a provider of automated technologies for test processes inherent in genetic analysis. The company offers infiniti systems and FDA cleared products and RUO products. Its infiniti system is designed for processing AutoGenomics' unique proprietary BioFilmChip …
  • Teledyne Technologies Incorporated (TDY):石油・ガス:M&Aディール及び事業提携情報
    Summary Teledyne Technologies Incorporated (Teledyne) is a provider of enabling technologies for industrial growth markets. The company’s product portfolio comprises digital imaging sensors, cameras and systems, infrared and X-ray spectra, monitoring and control instrumentation. It also offers elect …
  • Arabian Shield Cooperative Insurance Company:企業の戦略・SWOT・財務情報
    Arabian Shield Cooperative Insurance Company - Strategy, SWOT and Corporate Finance Report Summary Arabian Shield Cooperative Insurance Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operati …
  • Unisem (M) Berhad (UNISEM):企業の財務・戦略的SWOT分析
    Unisem (M) Berhad (UNISEM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Pharmascience Inc-製薬・医療分野:企業M&A・提携分析
    Summary Pharmascience Inc (Pharmascience) is a pharmaceutical company that develops, manufactures and markets medicinal products. The company offers generic, prescription, over-the-counter and private label OTC products. It offers drugs in therapeutic areas of anti-inflammatory, cancer, cardiovascul …
  • Msig Holdings (Asia) Pte. Ltd.:企業の戦略・SWOT・財務分析
    Msig Holdings (Asia) Pte. Ltd. - Strategy, SWOT and Corporate Finance Report Summary Msig Holdings (Asia) Pte. Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Abbott Diabetes Care Inc-医療機器分野:企業M&A・提携分析
    Summary Abbott Diabetes Care Inc (ADC), formerly TheraSense Inc, a subsidiary of Abbott Laboratories, is a medical device company that discovers, develops, manufactures, and markets pharmaceuticals and medical products for personal use and hospital use. The company’s products include glucose monitor …
  • NOF Corp (4403):企業の財務・戦略的SWOT分析
    NOF Corp (4403) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Pacific Drilling SA (PACD):企業の財務・戦略的SWOT分析
    Summary Pacific Drilling SA (Pacific Drilling) is an offshore drilling company that offers ultra deepwater drilling services to the oil and natural gas industry. The company provides contract services for floating rig drilling in ultra deepwater through its drill ships. It rents its drilling rigs, r …
  • CIMB Group Holdings Berhad:戦略・SWOT・企業財務分析
    CIMB Group Holdings Berhad - Strategy, SWOT and Corporate Finance Report Summary CIMB Group Holdings Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Lexicon Pharmaceuticals Inc (LXRX):企業の財務・戦略的SWOT分析
    Lexicon Pharmaceuticals Inc (LXRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Healthsense Inc:医療機器:M&Aディール及び事業提携情報
    Summary Healthsense Inc (Healthsense), a subsidiary of GreatCall Inc is a medical device company that provides remote monitoring services. The company offers technology-enabled care solutions, aging technology services, for the entire senior care continuum. Its products include eNeighbor remote moni …
  • Savara Inc (SVRA):製薬・医療:M&Aディール及び事業提携情報
    Summary Savara Inc (Savara) formerly Mast Therapeutics Inc is a clinical stage biopharmaceutical company, which develops therapies for the treatment of rare respiratory diseases, including cystic fibrosis (CF), and pulmonary alveolar proteinosis (PAP). The company’s lead product candidates include M …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆